A series of proceedings involving lawsuits combined into the federal multi-district Zyprexa liability litigation. The September 21, 2009, hearing involved two issues: the finality of any judgment entered (whether the court would retain jurisdictio...
The Amylin case is a 2-day trial to determine the validity of a "poison put" takeover defense that would protect Amylin's board of directors from being replaced. Carl Icahn, who owns 9.4% of Amylin, and the hedge fund Eastbourne Capital, which ow... View Proceeding
Settlement hearing. The court previously held a hearing on a on motion for a preliminary injunction in suit seeking to block acquisition of Genentech Inc (NYSE) by Roche Holdings Inc. View Proceeding
Suit alleging that various pharmaceutical companies failed to disclose the potential side effects of Fen Phen, a popular diet medication, which included primary hypertension and valve disease.
Suit brought by the state's attorney general against Pfizer's Pharmacia unit and other pharmaceutical manufacturers alleging they overcharged the state's Medicaid system. Litigation over "average wholesale prices" for medication charged to state M... View Proceeding